A Comprehensive Practice Guideline for Magnetic Resonance Imaging Compatibility in Implanted Neuromodulation Devices

Sayed, Dawood; Chakravarthy, Krishnan; Amirdelfan, Kasra; Kalia, Hemant; Meacham, Kathleen; Shirvalkar, Prasad; Falowski, Steven; Petersen, Erika; Hagedorn, Jonathan M; Pope, Jason E.; Leever, John; Deer, Timothy R.

doi:10.1111/ner.13233

Cited by 36 publications

(24 citation statements)

References 43 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The two commonly utilized intrathecal pump systems (Medtronic SynchroMed II and Flowonix Prometra II) have MRI Conditional labelling. 130 They are considered compatible with MRI when specific parameters are followed as specified by the device manufacturers. MRI safety profiles are found on each manufactures website and in online searchable databases.…”

Section: Data Evaluation and Discussionmentioning

confidence: 99%

“…With regard to device selection, it is imperative to understand the MRI conditionality of the devices. 130 In the non-cancer population, Desai et al found that 82–84% of SCS-implanted patients were expected to need at least one MRI within 5 years of implant. Within 10 years of implantation, 59–74% of all patients implanted were likely to require non-spine MRI.…”

Section: Data Evaluation and Discussionmentioning

confidence: 99%

See 1 more Smart Citation

The American Society of Pain and Neuroscience (ASPN) Best Practices and Guidelines for the Interventional Management of Cancer-Associated Pain

Aman¹,

Mahmoud²,

Deer³

et al. 2021

JPR

Self Cite

View full text Add to dashboard Cite

Moderate to severe pain occurs in many cancer patients during their clinical course and may stem from the primary pathology, metastasis, or as treatment side effects. Uncontrolled pain using conservative medical therapy can often lead to patient distress, loss of productivity, shorter life expectancy, longer hospital stays, and increase in healthcare utilization. Various publications shed light on strategies for conservative medical management for cancer pain and a few international publications have reviewed limited interventional data. Our multi-institutional working group was assembled to review and highlight the body of evidence that exists for opioid utilization for cancer pain, adjunct medication such as ketamine and methadone and interventional therapies. We discuss neurolysis via injections, neuromodulation including targeted drug delivery and spinal cord stimulation, vertebral tumor ablation and augmentation, radiotherapy and surgical techniques. In the United States, there is a significant variance in the interventional treatment of cancer pain based on fellowship training. As a first of its kind, this best practices and interventional guideline will offer evidenced-based recommendations for reducing pain and suffering associated with malignancy.

show abstract

Section: Data Evaluation and Discussionmentioning

confidence: 99%

Section: Data Evaluation and Discussionmentioning

confidence: 99%

The American Society of Pain and Neuroscience (ASPN) Best Practices and Guidelines for the Interventional Management of Cancer-Associated Pain

Aman¹,

Mahmoud²,

Deer³

et al. 2021

JPR

Self Cite

View full text Add to dashboard Cite

show abstract

“…As the need for MRI has became more common for diagnosis and disease surveillance, device selection based on MRI compatibility is important. 69 About 90% of patients with an implanted SCS device will require an MRI over a 10-year time horizon. 70 Counseling of patients regarding the use of MRI-conditional SCS systems should be considered prior to implantation.…”

Section: Ethicsmentioning

confidence: 99%

Patient Selection for Spinal Cord Stimulation in Treatment of Pain: Sequential Decision-Making Model — A Narrative Review

Goudman¹,

Rigoard²,

Billot³

et al. 2022

JPR

View full text Add to dashboard Cite

Despite the well-known efficacy of spinal cord stimulation (SCS) in chronic pain management, patient selection in clinical practice remains challenging. The aim of this review is to provide an overview of the factors that can influence the process of patient selection for SCS treatment. A sequential decision-making model is presented within a tier system that operates in clinical practice. The first level incorporates the underlying disease as a primary indication for SCS, country-related reimbursement rules, and SCS screening–trial criteria in combination with underlying psychological factors as initial selection criteria in evaluating patient eligibility for SCS. The second tier is aligned with the individualized approach within precision pain medicine, whereby individual goals and expectations and the potential need for preoperative optimizations are emphasized. Additionally, this tier relies on results from prediction models to provide an estimate of the efficacy of SCS in the long term. In the third tier, selection bias, MRI compatibility, and ethical beliefs are included, together with recent technological innovations, superiority of specific stimulation paradigms, and new feedback systems that could indirectly influence the decision-making of the physician. Both patients and physicians should be aware of the different aspects that influence patient selection in relation to SCS for pain management to make an independent decision on whether or not to initiate a treatment trajectory with SCS.

show abstract

“…The MRI properties of available devices were recently published and should serve as a guide. 16 Documentation of any allergies to adhesives or cleansers is critical. Improving the health status may require a multidisciplinary approach, and APPs should work closely with the other medical teams involved to optimize each patient’s health.…”

Section: Surgical Preparationmentioning

confidence: 99%

The Team Approach to Spinal Cord and Dorsal Root Ganglion Stimulation: A Guide for the Advanced Practice Provider

Hagedorn

Misercola

Comer

et al. 2021

Mayo Clinic Proceedings: Innovations, Quality & Outcomes

Self Cite

View full text Add to dashboard Cite

A Comprehensive Practice Guideline for Magnetic Resonance Imaging Compatibility in Implanted Neuromodulation Devices

Cited by 36 publications

References 43 publications

The American Society of Pain and Neuroscience (ASPN) Best Practices and Guidelines for the Interventional Management of Cancer-Associated Pain

The American Society of Pain and Neuroscience (ASPN) Best Practices and Guidelines for the Interventional Management of Cancer-Associated Pain

Patient Selection for Spinal Cord Stimulation in Treatment of Pain: Sequential Decision-Making Model — A Narrative Review

The Team Approach to Spinal Cord and Dorsal Root Ganglion Stimulation: A Guide for the Advanced Practice Provider

Contact Info

Product

Resources

About